Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03709147
Title Metformin Plus/Minus Fasting Mimicking Diet to Target the Metabolic Vulnerabilities of LKB1-inactive Lung Adenocarcinoma (FAME)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Marina Garassino
Indications

lung adenocarcinoma

Therapies

Carboplatin + Metformin + Pembrolizumab + Pemetrexed Disodium

Cisplatin + Metformin + Pembrolizumab + Pemetrexed Disodium

Age Groups: senior | adult
Covered Countries ITA

Additional content available in CKB BOOST